Baltimore, MD, August 10, 2016/PR Newswire/ – Paragon Bioservices, Inc., a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today that Mark Adams has joined the company as Vice President of Project Management. Mr. Adams will be responsible for directing Paragon’s Project Management team.

Mr. Adams comes to Paragon with a wealth of knowledge and over 30 years of industry experience at leading companies such as Shire Human Genetic Therapies, Genzyme Transgenics, Lonza Biologics and, most recently, at Cytovance Biologics. As VP of Program Management for Cytovance, Mark established a Program Management team that led cross-functional project teams, driving milestone deliverables for over 25 client process development and GMP manufacturing programs. He has extensive knowledge and experience in biological drug development. Mr. Adams holds a M.Sc. in Biochemistry from University College, Cork, Ireland.

Read the rest of the press release on PR Newswire